Symposia: Chronic Lymphocytic Leukemia: Basic and Translational
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Lymphoid Leukemias, Fundamental Science, Apoptosis, Artificial intelligence (AI), Translational Research, CLL, Bioinformatics, Diseases, Immune mechanism, Immunology, Lymphoid Malignancies, Metabolism, Computational biology, Biological Processes, Molecular biology, Technology and Procedures, Study Population, Human, Multi-systemic interactions, Profiling, Pathogenesis, Machine learning, Molecular testing, Omics technologies
Type: Oral
Hematology Disease Topics & Pathways:
Research, Lymphoid Leukemias, Fundamental Science, Apoptosis, Artificial intelligence (AI), Translational Research, CLL, Bioinformatics, Diseases, Immune mechanism, Immunology, Lymphoid Malignancies, Metabolism, Computational biology, Biological Processes, Molecular biology, Technology and Procedures, Study Population, Human, Multi-systemic interactions, Profiling, Pathogenesis, Machine learning, Molecular testing, Omics technologies
Saturday, December 7, 2024: 9:30 AM-11:00 AM
Marriott Grand Ballroom 5-6
(Marriott Marquis San Diego Marina)
Moderators:
Lili Wang, MD, PhD, City of Hope
and
Elisa Ten Hacken, PhD,
Disclosures:
No relevant conflicts of interest to declare.
Presentations in this session will cover emerging novel preclinical strategies for therapeutically targeting CLL, including targeting of disease reservoirs (residual disease, proliferative fraction). In addition, data on CLL-related T cell and immune function will be presented with potential therapeutic and/or prognostic significance.
9:30 AM
9:45 AM
10:00 AM
10:15 AM
10:30 AM
10:45 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH